CME Quote, Financials, Valuation and Earnings

Coinbase Global has a net margin of 57.34% compared to CME Group's net margin of 56.84%. CME Group's return on equity of 12.94% beat Coinbase Global's return on equity of 30.9%.

CME Group has a consensus price target of $260.24, signalling downside risk potential of -3.03%. On the other hand Coinbase Global has an analysts' consensus of $314.12 which suggests that it could grow by 83.95%. Given that Coinbase Global has higher upside potential than CME Group, analysts believe Coinbase Global is more attractive than CME Group.

CME Group has a beta of 0.427, which suggesting that the stock is 57.303% less volatile than S&P 500. In comparison Coinbase Global has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

CME Group has a quarterly dividend of $1.25 per share corresponding to a yield of 3.91%. Coinbase Global offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CME Group pays 101.66% of its earnings as a dividend. Coinbase Global pays out -- of its earnings as a dividend.

CME Group quarterly revenues are $1.5B, which are smaller than Coinbase Global quarterly revenues of $2.3B. CME Group's net income of $874.6M is lower than Coinbase Global's net income of $1.3B. Notably, CME Group's price-to-earnings ratio is 27.75x while Coinbase Global's PE ratio is 17.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 15.76x versus 7.02x for Coinbase Global. Usually stocks with elevated PS ratios are considered overvalued.

Intercontinental Exchange has a net margin of 57.34% compared to CME Group's net margin of 23.04%. CME Group's return on equity of 12.94% beat Intercontinental Exchange's return on equity of 10.29%.

CME Group has a consensus price target of $260.24, signalling downside risk potential of -3.03%. On the other hand Intercontinental Exchange has an analysts' consensus of $189.19 which suggests that it could grow by 12.91%. Given that Intercontinental Exchange has higher upside potential than CME Group, analysts believe Intercontinental Exchange is more attractive than CME Group.

CME Group has a beta of 0.427, which suggesting that the stock is 57.303% less volatile than S&P 500. In comparison Intercontinental Exchange has a beta of 1.094, suggesting its more volatile than the S&P 500 by 9.398%.

CME Group has a quarterly dividend of $1.25 per share corresponding to a yield of 3.91%. Intercontinental Exchange offers a yield of 1.09% to investors and pays a quarterly dividend of $0.48 per share. CME Group pays 101.66% of its earnings as a dividend. Intercontinental Exchange pays out 37.73% of its earnings as a dividend. Intercontinental Exchange's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

CME Group quarterly revenues are $1.5B, which are smaller than Intercontinental Exchange quarterly revenues of $3B. CME Group's net income of $874.6M is higher than Intercontinental Exchange's net income of $698M. Notably, CME Group's price-to-earnings ratio is 27.75x while Intercontinental Exchange's PE ratio is 35.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 15.76x versus 8.20x for Intercontinental Exchange. Usually stocks with elevated PS ratios are considered overvalued.

Moodys has a net margin of 57.34% compared to CME Group's net margin of 23.62%. CME Group's return on equity of 12.94% beat Moodys's return on equity of 54.32%.

CME Group has a consensus price target of $260.24, signalling downside risk potential of -3.03%. On the other hand Moodys has an analysts' consensus of $540.34 which suggests that it could grow by 22.14%. Given that Moodys has higher upside potential than CME Group, analysts believe Moodys is more attractive than CME Group.

CME Group has a beta of 0.427, which suggesting that the stock is 57.303% less volatile than S&P 500. In comparison Moodys has a beta of 1.384, suggesting its more volatile than the S&P 500 by 38.384%.

CME Group has a quarterly dividend of $1.25 per share corresponding to a yield of 3.91%. Moodys offers a yield of 0.79% to investors and pays a quarterly dividend of $0.94 per share. CME Group pays 101.66% of its earnings as a dividend. Moodys pays out 30.13% of its earnings as a dividend. Moodys's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

CME Group quarterly revenues are $1.5B, which are smaller than Moodys quarterly revenues of $1.7B. CME Group's net income of $874.6M is higher than Moodys's net income of $395M. Notably, CME Group's price-to-earnings ratio is 27.75x while Moodys's PE ratio is 39.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 15.76x versus 11.40x for Moodys. Usually stocks with elevated PS ratios are considered overvalued.

Nasdaq has a net margin of 57.34% compared to CME Group's net margin of 17.49%. CME Group's return on equity of 12.94% beat Nasdaq's return on equity of 10.19%.

CME Group has a consensus price target of $260.24, signalling downside risk potential of -3.03%. On the other hand Nasdaq has an analysts' consensus of $88.39 which suggests that it could grow by 19.78%. Given that Nasdaq has higher upside potential than CME Group, analysts believe Nasdaq is more attractive than CME Group.

CME Group has a beta of 0.427, which suggesting that the stock is 57.303% less volatile than S&P 500. In comparison Nasdaq has a beta of 1.021, suggesting its more volatile than the S&P 500 by 2.075%.

CME Group has a quarterly dividend of $1.25 per share corresponding to a yield of 3.91%. Nasdaq offers a yield of 1.3% to investors and pays a quarterly dividend of $0.24 per share. CME Group pays 101.66% of its earnings as a dividend. Nasdaq pays out 48.43% of its earnings as a dividend. Nasdaq's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but CME Group's is not.

CME Group quarterly revenues are $1.5B, which are smaller than Nasdaq quarterly revenues of $2B. CME Group's net income of $874.6M is higher than Nasdaq's net income of $355M. Notably, CME Group's price-to-earnings ratio is 27.75x while Nasdaq's PE ratio is 38.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CME Group is 15.76x versus 5.78x for Nasdaq. Usually stocks with elevated PS ratios are considered overvalued.